Inovio Pharmaceuticals Inc (INO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. It is advancing a preclinical and clinical stage product pipeline to fight cancers of the cervix, prostate, breast, bladder, head and neck, lung, and pancreas; and to protect against and eliminate infectious diseases such as HIV, hepatitis, Ebola, Zika virus and Middle East respiratory syndrome (MERS). Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals Inc (INO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Inovio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Inovio Pharma Acquires DNA Therapies For Alzheimers Disease And Multiple Sclerosis From Fudan University 13
Partnerships 14
Inovio Pharma Enters into Partnership with Coalition for Epidemic Preparedness Innovations 14
Inovio Pharma and Parker Institute for Cancer Immunotherapy Enter into Agreement 15
Inovio Pharma Enters into Agreement with Genentech 16
Inovio Pharma and Regeneron Pharma Enter into Agreement 17
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 18
Inovio Pharma Enters into Research Agreement with Wistar Institute 19
GeneOne Life Science Enters into Research Agreement with Inovio Pharma 20
Inovio Pharma Enters into Co-Development Agreement with GeneOne Life Science 21
Inovio Pharma Amends Agreement with GeneOne 22
Path Malaria Vaccine Initiative And Inovio Pharma Partner To Accelerate Malaria Vaccine Development And Delivery Technologies 23
Licensing Agreements 24
MedImmune Enters into Licensing Agreement with Inovio Pharma 24
Equity Offering 25
Inovio Pharma Plans to Raise up to USD250 Million in Public Offering of Shares 25
Inovio Pharma Raises USD75 Million in Public Offering of Shares 26
Inovio Pharma to Raise up to USD35 Million in Private Placement of Shares 28
Inovio Pharma Raises USD6.3 Million in Public Offering of Shares 29
Inovio Pharma Raises USD87.4 Million Public Offering of Shares 30
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 32
Inovio Pharma Completes Public Offering Of Common Stock And Warrants For US$15 Million 33
Inovio Pharmaceuticals Inc - Key Competitors 35
Inovio Pharmaceuticals Inc - Key Employees 36
Inovio Pharmaceuticals Inc - Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
May 09, 2018: Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results 39
Mar 14, 2018: Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results 41
Nov 08, 2017: Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results 44
Aug 08, 2017: Inovio Pharmaceuticals Reports 2017 Second Quarter Financial Results 47
May 10, 2017: Inovio Pharmaceuticals Reports 2017 First Quarter Financial Results 50
Mar 15, 2017: Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results 52
Corporate Communications 55
May 24, 2018: Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D 55
Dec 11, 2017: Inovio Pharmaceuticals Promotes Dr. Laurent Humeau to Senior Vice President, Research & Development 56
Dec 06, 2017: Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors 57
Jun 28, 2017: Inovio Announces Leadership Appointments 58
Mar 21, 2017: George Bickerstaff Elected to Inovios Board of Directors 59
Government and Public Interest 60
Feb 12, 2018: Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding to Advance Vaccines Against Tuberculosis & Malaria 60
Jan 18, 2018: The Wistar Institute Awarded More Than $1.4 Million to Create a Malaria Vaccine Through Synthetic DNA-Based Technology 61
Product News 62
Sep 21, 2017: Inovio dMAb Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies 62
09/18/2017: Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine Against Deadly MERS Infection 64
Jul 06, 2017: Inovios DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation 65
Feb 27, 2017: Inovios SynCon WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy 67
Clinical Trials 69
Oct 24, 2017: Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study 69
Feb 23, 2017: Inovio Reports New Positive Clinical Data on MERS Vaccine GLS-5300 70
Other Significant Developments 71
Jan 22, 2018: Inovio Pharmaceuticals Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models 71
Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72

List Of Tables

List of Tables
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Inovio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Inovio Pharma Acquires DNA Therapies For Alzheimers Disease And Multiple Sclerosis From Fudan University 13
Inovio Pharma Enters into Partnership with Coalition for Epidemic Preparedness Innovations 14
Inovio Pharma and Parker Institute for Cancer Immunotherapy Enter into Agreement 15
Inovio Pharma Enters into Agreement with Genentech 16
Inovio Pharma and Regeneron Pharma Enter into Agreement 17
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 18
Inovio Pharma Enters into Research Agreement with Wistar Institute 19
GeneOne Life Science Enters into Research Agreement with Inovio Pharma 20
Inovio Pharma Enters into Co-Development Agreement with GeneOne Life Science 21
Inovio Pharma Amends Agreement with GeneOne 22
Path Malaria Vaccine Initiative And Inovio Pharma Partner To Accelerate Malaria Vaccine Development And Delivery Technologies 23
MedImmune Enters into Licensing Agreement with Inovio Pharma 24
Inovio Pharma Plans to Raise up to USD250 Million in Public Offering of Shares 25
Inovio Pharma Raises USD75 Million in Public Offering of Shares 26
Inovio Pharma to Raise up to USD35 Million in Private Placement of Shares 28
Inovio Pharma Raises USD6.3 Million in Public Offering of Shares 29
Inovio Pharma Raises USD87.4 Million Public Offering of Shares 30
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 32
Inovio Pharma Completes Public Offering Of Common Stock And Warrants For US$15 Million 33
Inovio Pharmaceuticals Inc, Key Competitors 35
Inovio Pharmaceuticals Inc, Key Employees 36
Inovio Pharmaceuticals Inc, Subsidiaries 38

List Of Figures

List of Figures
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Inovio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

Inovio Pharmaceuticals Inc (INO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases.

USD 250 View Report

Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review

Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Pivot Pharmaceuticals Inc (PVOTF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pivot Pharmaceuticals Inc (Pivot Pharmaceuticals), formerly Neurokine Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of cannabinoid based neutraceutical and pharmaceutical products. The companys major

USD 250 View Report

Fog Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fog Pharmaceuticals Inc (Fog Pharmaceuticals) is a clinical-stage biotechnology company that discovers and develops next-generation peptide inhibitors that target traditionally undruggable intracellular protein-protein interactions. The company develops cell-penetrating miniproteins (CPMPs),

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available